We updated our model as in 2Q24 Materialise continued on its growth path, generating record-high quarterly revenues with all three of its business segments reporting increased revenues. Especially the Medical segment turned in another strong performance, growing by 13%, while also its Software and Manufacturing segments posted higher revenues.
We also welcome that -in another step forward- Materialise acquired begin 2H24 FEops, a Belgian company that develops AI-driven simulation technology to improve procedure efficiency and clinical outcomes for structural heart interventions. The acquisition positions Materialise to advance the personalized treatment of patients with heart diseases.